CAR-T Clinical Breakthrough: Carl June on Next-Gen Therapies Making Further Progress [Exclusive Interview]
NQ Score
85/100
N1 Content Completeness
9
AI Summary (NQ-processed)
Carl H. June, a pioneer of CAR-T therapy, reveals that Emily, the first pediatric patient, is now 22 and cancer-free. He anticipates further advancements in next-generation cancer treatments.
AI Analysis
Frequently Asked Questions
- Q: Who was the first pediatric patient for CAR-T therapy?
- A: Emily Whitehead, treated in 2012, remains cancer-free at age 22.
- Q: Where does Dr. Carl June conduct his research?
- A: At the University of Pennsylvania, leading immunotherapy research.
- Q: How effective is CAR-T therapy?
- A: Over 60,000 patients treated worldwide, with high efficacy in blood cancers.